Enhanced the infiltration of immune cells in tumor site, as CCR9+CXCR3+CD4+ T cells were recruited to the tumor microenvironment and the ratio of CD4+ T cells to CD4+FoxP3+ T cells (Tregs) was enhanced. The gene discussed is CCR9; the disease is neoplasm.